Please enable JavaScript to continue using this application.

Compare $MNOV vs $SPRO | Chartloom

Compare

$MNOV vs $SPRO

MediciNova Inc · Spero Therapeutics Inc

MNOV

MediciNova Inc

SPRO

Spero Therapeutics Inc

Compare $MNOV vs $SPRO

Comparing MediciNova Inc and Spero Therapeutics Inc

MNOVMediciNova Inc

SPROSpero Therapeutics Inc

MNOVMediciNova Inc

Market cap

$75M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

583.8%

YTD performance

14.3%

52W performance

24.6%

FCF yield

-12.2%

SPROSpero Therapeutics Inc

Market cap

$69M

P/E (TTM)

9.42x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-3.3%

YTD performance

-48.9%

52W performance

-47.4%

FCF yield

28.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MNOV

SPRO

Detailed metrics comparison

MNOV

MediciNova Inc

SPRO

Spero Therapeutics Inc

Market Cap

MNOV$75M

SPRO$69M

Enterprise Value

MNOV$49M

SPRO$19M

Price

MNOV$1.52

SPRO$1.20

P/E Ratio

MNOVN/A

SPRO9.42x

P/S Ratio

MNOV81.28x

SPRO1.48x

EV/Sales

MNOV53.67x

SPRO0.40x

EV/EBITDA

MNOV0.00x

SPRO0.78x

P/B Ratio

MNOV2.35x

SPRO1.57x

P/FCF Ratio

MNOVN/A

SPRO3.55x

EV/FCF

MNOV-5.41x

SPRO0.96x

PEG Ratio

MNOVN/A

SPRON/A

Forward P/E (NTM)

MNOVN/A

SPRON/A

Forward P/S (NTM)

MNOVN/A

SPRON/A

Revenue (TTM)

MNOV$920K

SPRO$47M

Revenue Growth (YoY)

MNOV583.8%

SPRO-3.3%

Forward Rev Growth

MNOV-2.9%

SPRO300.0%

Gross Margin (TTM)

MNOV37.8%

SPRO0.0%

Operating Margin (TTM)

MNOV0.0%

SPRO22.1%

EBITDA Margin (TTM)

MNOV-1285.4%

SPRO51.2%

Net Margin (TTM)

MNOV-1168.3%

SPRO15.7%

FCF Margin (TTM)

MNOV-991.3%

SPRO41.7%

Net Income (TTM)

MNOV$-11M

SPRO$7M

FCF (TTM)

MNOV$-9M

SPRO$20M

EPS (TTM)

MNOV-$0.22

SPRO$0.13

ROE (TTM)

MNOV-2651.0%

SPRO16.2%

ROA (TTM)

MNOV-2439.0%

SPRO12.6%

ROIC (TTM)

MNOV-2651.0%

SPRO16.2%

Cash

MNOV$25M

SPRO$51M

Debt

MNOV$0

SPRO$0

Net Cash/Debt

MNOV$25M

SPRO$51M

Current Ratio (TTM)

MNOV8.75x

SPRO6.12x

Quick Ratio (TTM)

MNOV8.58x

SPRO6.03x

Debt/Equity (TTM)

MNOV0.00x

SPRO0.00x

Debt/Assets (TTM)

MNOV0.0%

SPRO0.0%

Interest Coverage (TTM)

MNOVN/A

SPRON/A

Net Debt/EBITDA (TTM)

MNOV0.00x

SPRO0.00x

Beta

MNOV0.69

SPRO1.54

52W Performance

MNOV24.6%

SPRO-47.4%

YTD Performance

MNOV14.3%

SPRO-48.9%

% from 52W High

MNOV-61.0%

SPRO-61.0%

% from 52W Low

MNOV30.1%

SPRO11.1%

Asset Turnover (TTM)

MNOV0.02x

SPRO1.00x

FCF Yield (TTM)

MNOV-12.2%

SPRO28.2%

Earnings Yield (TTM)

MNOV-14.4%

SPRO10.6%

Dividend Yield (TTM)

MNOVN/A

SPRON/A

Rule of 40

MNOV-407.5

SPRO38.4

EV/GP/RG

MNOVN/A

SPRON/A

Ticker research

View MNOV research View SPRO research

Metric	MNOV MediciNova Inc	SPRO Spero Therapeutics Inc
Market & Valuation
Market Cap	$75M	$69M
Enterprise Value	$49M	$19M
Price	$1.52	$1.20
P/E Ratio	N/A	9.42x
P/S Ratio	81.28x	1.48x
EV/Sales	53.67x	0.40x
EV/EBITDA	0.00x	0.78x
P/B Ratio	2.35x	1.57x
P/FCF Ratio	N/A	3.55x
EV/FCF	-5.41x	0.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$920K	$47M
Revenue Growth (YoY)	583.8%	-3.3%
Forward Rev Growth	-2.9%	300.0%
Profitability
Gross Margin (TTM)	37.8%	0.0%
Operating Margin (TTM)	0.0%	22.1%
EBITDA Margin (TTM)	-1285.4%	51.2%
Net Margin (TTM)	-1168.3%	15.7%
FCF Margin (TTM)	-991.3%	41.7%
Net Income (TTM)	$-11M	$7M
FCF (TTM)	$-9M	$20M
EPS (TTM)	-$0.22	$0.13
ROE (TTM)	-2651.0%	16.2%
ROA (TTM)	-2439.0%	12.6%
ROIC (TTM)	-2651.0%	16.2%
Financial Health
Cash	$25M	$51M
Debt	$0	$0
Net Cash/Debt	$25M	$51M
Current Ratio (TTM)	8.75x	6.12x
Quick Ratio (TTM)	8.58x	6.03x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.69	1.54
52W Performance	24.6%	-47.4%
YTD Performance	14.3%	-48.9%
% from 52W High	-61.0%	-61.0%
% from 52W Low	30.1%	11.1%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	1.00x
FCF Yield (TTM)	-12.2%	28.2%
Earnings Yield (TTM)	-14.4%	10.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-407.5	38.4
EV/GP/RG	N/A	N/A
Ticker research	View MNOV research	View SPRO research

Valuation

P/E Ratio

SPRO

9.42x

P/S Ratio

SPRO

1.48x

MNOV

81.28x

EV/FCF

MNOV

-5.41x

SPRO

0.96x

Growth & revenue

Revenue Growth TTM

MNOV

583.8%

SPRO

-3.3%

Forward Revenue Growth

SPRO

300.0%

MNOV

-2.9%

Profitability & performance

Gross Margin

MNOV

37.8%

SPRO

0.0%

ROE

SPRO

16.2%

MNOV

-2651.0%

FCF Yield %

SPRO

28.2%

MNOV

-12.2%

52-Week Performance

MNOV

24.6%

SPRO

-47.4%

Detailed metrics comparison

MNOV

MediciNova Inc

SPRO

Spero Therapeutics Inc

Market Cap

MNOV$75M

SPRO$69M

Enterprise Value

MNOV$49M

SPRO$19M

Price

MNOV$1.52

SPRO$1.20

P/E Ratio

MNOVN/A

SPRO9.42x

P/S Ratio

MNOV81.28x

SPRO1.48x

EV/Sales

MNOV53.67x

SPRO0.40x

EV/EBITDA

MNOV0.00x

SPRO0.78x

P/B Ratio

MNOV2.35x

SPRO1.57x

P/FCF Ratio

MNOVN/A

SPRO3.55x

EV/FCF

MNOV-5.41x

SPRO0.96x

PEG Ratio

MNOVN/A

SPRON/A

Forward P/E (NTM)

MNOVN/A

SPRON/A

Forward P/S (NTM)

MNOVN/A

SPRON/A

Revenue (TTM)

MNOV$920K

SPRO$47M

Revenue Growth (YoY)

MNOV583.8%

SPRO-3.3%

Forward Rev Growth

MNOV-2.9%

SPRO300.0%

Gross Margin (TTM)

MNOV37.8%

SPRO0.0%

Operating Margin (TTM)

MNOV0.0%

SPRO22.1%

EBITDA Margin (TTM)

MNOV-1285.4%

SPRO51.2%

Net Margin (TTM)

MNOV-1168.3%

SPRO15.7%

FCF Margin (TTM)

MNOV-991.3%

SPRO41.7%

Net Income (TTM)

MNOV$-11M

SPRO$7M

FCF (TTM)

MNOV$-9M

SPRO$20M

EPS (TTM)

MNOV-$0.22

SPRO$0.13

ROE (TTM)

MNOV-2651.0%

SPRO16.2%

ROA (TTM)

MNOV-2439.0%

SPRO12.6%

ROIC (TTM)

MNOV-2651.0%

SPRO16.2%

Cash

MNOV$25M

SPRO$51M

Debt

MNOV$0

SPRO$0

Net Cash/Debt

MNOV$25M

SPRO$51M

Current Ratio (TTM)

MNOV8.75x

SPRO6.12x

Quick Ratio (TTM)

MNOV8.58x

SPRO6.03x

Debt/Equity (TTM)

MNOV0.00x

SPRO0.00x

Debt/Assets (TTM)

MNOV0.0%

SPRO0.0%

Interest Coverage (TTM)

MNOVN/A

SPRON/A

Net Debt/EBITDA (TTM)

MNOV0.00x

SPRO0.00x

Beta

MNOV0.69

SPRO1.54

52W Performance

MNOV24.6%

SPRO-47.4%

YTD Performance

MNOV14.3%

SPRO-48.9%

% from 52W High

MNOV-61.0%

SPRO-61.0%

% from 52W Low

MNOV30.1%

SPRO11.1%

Asset Turnover (TTM)

MNOV0.02x

SPRO1.00x

FCF Yield (TTM)

MNOV-12.2%

SPRO28.2%

Earnings Yield (TTM)

MNOV-14.4%

SPRO10.6%

Dividend Yield (TTM)

MNOVN/A

SPRON/A

Rule of 40

MNOV-407.5

SPRO38.4

EV/GP/RG

MNOVN/A

SPRON/A

Ticker research

View MNOV research View SPRO research

Metric	MNOV MediciNova Inc	SPRO Spero Therapeutics Inc
Market & Valuation
Market Cap	$75M	$69M
Enterprise Value	$49M	$19M
Price	$1.52	$1.20
P/E Ratio	N/A	9.42x
P/S Ratio	81.28x	1.48x
EV/Sales	53.67x	0.40x
EV/EBITDA	0.00x	0.78x
P/B Ratio	2.35x	1.57x
P/FCF Ratio	N/A	3.55x
EV/FCF	-5.41x	0.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$920K	$47M
Revenue Growth (YoY)	583.8%	-3.3%
Forward Rev Growth	-2.9%	300.0%
Profitability
Gross Margin (TTM)	37.8%	0.0%
Operating Margin (TTM)	0.0%	22.1%
EBITDA Margin (TTM)	-1285.4%	51.2%
Net Margin (TTM)	-1168.3%	15.7%
FCF Margin (TTM)	-991.3%	41.7%
Net Income (TTM)	$-11M	$7M
FCF (TTM)	$-9M	$20M
EPS (TTM)	-$0.22	$0.13
ROE (TTM)	-2651.0%	16.2%
ROA (TTM)	-2439.0%	12.6%
ROIC (TTM)	-2651.0%	16.2%
Financial Health
Cash	$25M	$51M
Debt	$0	$0
Net Cash/Debt	$25M	$51M
Current Ratio (TTM)	8.75x	6.12x
Quick Ratio (TTM)	8.58x	6.03x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.69	1.54
52W Performance	24.6%	-47.4%
YTD Performance	14.3%	-48.9%
% from 52W High	-61.0%	-61.0%
% from 52W Low	30.1%	11.1%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	1.00x
FCF Yield (TTM)	-12.2%	28.2%
Earnings Yield (TTM)	-14.4%	10.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-407.5	38.4
EV/GP/RG	N/A	N/A
Ticker research	View MNOV research	View SPRO research